(Q51139530)

English

Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.

scientific article published in September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

1 reference

based on heuristic

inferred from title

author name string

Keisaku Fujimoto

1

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

Yoshimichi Komatsu

2

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

Masanori Yasuo

3

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

Kazuhisa Urushihata

4

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

Keishi Kubo

5

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

language of work or name

0 references

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

Journal of Asthma

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

43

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

7

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

501-507

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Impact of inhaled salmeterol/fluticasone propionate combination product versus budesonide on the health-related quality of life of patients with asthma

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Salmeterol 100 microg: an analysis of its tolerability in single- and chronic-dose studies

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Comparison of the Relative Efficacy of Formoterol and Salmeterol in Asthmatic Patients

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers

1 reference

https://api.crossref.org/works/10.1080%2F02770900600758432

21 January 2018

Identifiers

10.1080/02770900600758432

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

release_j75xkne3ffcnhbhsa4m7l6qvki

1 reference

https://api.fatcat.wiki/v0/release/j75xkne3ffcnhbhsa4m7l6qvki

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/16939989

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51139530&oldid=1843405368"